Kathleen T. Karloff, CEO / Chairman at INVO Bioscience, Inc. (IVOB), sold 400,000 shares at $0.15 ($60K) on 2017-02-15, disclosed to the SEC on 2017-07-03.
Open-market sale of $60k IVOB by CEO / Chairman. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.